Active Biotech AB | Mutual Funds
Mutual Funds that own Active Biotech AB
Tredje AP Fonden
3,652,804
2.52%
-750,513
0%
06/30/2017
Fjarde AP Fonden
2,878,842
1.98%
2,878,842
0%
12/31/2016
Rhenman & Partners Fund - Healthcare Equity L/S
1,274,022
0.88%
-75,164
0.04%
12/31/2017
Nordea Institutionella Aktiefonden Sverige
934,365
0.64%
56,700
0.05%
05/31/2018
Gladiator
665,159
0.46%
665,159
0.05%
12/31/2016
SEB Sverige Indexfond
296,286
0.2%
0
0.01%
12/31/2017
67,368
0.05%
0
0.01%
09/11/2018
Nordea Donationsmedelsfond
53,932
0.04%
1,123
0.02%
05/31/2018
Nordea Asset Allocation Fund - Futura
40,900
0.03%
-9,888
0%
05/31/2018
Catella Sverige Index
31,009
0.02%
0
0.01%
08/31/2018
| Address |
Scheelevägen 22
Lund SN 223 63
Sweden
|
|
Employees
|
- |
| Website |
http://www.activebiotech.com |
| Updated |
07/08/2019 |
| Active Biotech AB develops pharmaceutical preparations. It develops pharmaceutical products within medical areas where the immune defense is of significant importance, including neurodegenerative diseases, autoimmune, inflammatory disease and various forms of cancer. The company's project portfolio comprises small, orally active immunomodulatory molecules as well as antibody-based immunotherapy. |
